Researchers identified key ancestral contributions among patients with high-risk melanoma in a US intergroup phase 3 trial. Most cases genetically clustered with European reference populations, with smaller subsets aligning with admixed American and East Asian ancestries.
2025
Immunotherapy Improves Overall Survival in Women With Genital Tract Melanoma
Overall survival (OS) in women with genital tract melanoma (GTM) is improved with immunotherapy, according to study findings published in Melanoma Research.
Exploring the Long-Term Psychosocial Impacts of Stage IV Melanoma in Survivors
Stage IV melanoma survivors face persistent adverse effects and distress, highlighting the need for targeted psychological support and care.
ctDNA Monitoring Can Predict Early Melanoma Recurrence Following Resection
Data come from patients with stage 3 melanoma enrolled in a phase 3 randomized trial and showed that detection of circulating tumor DNA (ctDNA) prior to adjuvant systemic therapy can predict risk of early recurrence.